ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,297.48
0.01%
US Tech 100
18,057.20
-0.12%
다우존스 지수
39,934.39
0.16%
Bitcoin
66,720.05
2.26%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Oncocyte Corporation (OCX)

  7. Oncocyte Corporation (OCX) 뉴스

OCX

Oncocyte (OCX)

Oncocyte Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:OCX
일자시간출처헤드라인심볼기업
2024/05/1605:05GlobeNewswire Inc.Oncocyte Reports First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
2024/05/1321:00GlobeNewswire Inc.Oncocyte to Announce First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
2024/05/1106:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCXOncocyte Corporation
2024/05/0722:19GlobeNewswire Inc.PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics MarketplaceNASDAQ:OCXOncocyte Corporation
2024/04/1219:00GlobeNewswire Inc.Oncocyte Reports Full Year 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
2024/04/1210:46GlobeNewswire Inc.Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesNASDAQ:OCXOncocyte Corporation
2024/04/1206:30GlobeNewswire Inc.Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayNASDAQ:OCXOncocyte Corporation
2024/04/1005:05GlobeNewswire Inc.Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
2024/01/2406:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
2024/01/1622:00GlobeNewswire Inc.Oncocyte to Present at the Sequire Investor Summit in Puerto RicoNASDAQ:OCXOncocyte Corporation
2023/12/0622:00GlobeNewswire Inc.Oncocyte Begins FDA Submissions Process for VitaGraft Transplant AssaysNASDAQ:OCXOncocyte Corporation
2023/11/1007:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
2023/11/0921:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
2023/11/0921:00GlobeNewswire Inc.Oncocyte Reports Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
2023/11/0321:30GlobeNewswire Inc.Oncocyte to Announce Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
2023/10/1305:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
2023/10/1105:48Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OCXOncocyte Corporation
2023/10/0605:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
2023/09/2022:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
2023/08/2905:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
2023/08/1807:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
2023/08/1105:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
2023/08/1020:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
2023/07/2522:08GlobeNewswire Inc.VitaGraft Kidney Expands Utility in Recurrent Primary Disease PatientsNASDAQ:OCXOncocyte Corporation
2023/07/2506:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
2023/07/2502:35GlobeNewswire Inc.Oncocyte Announces 1-For-20 Reverse Stock SplitNASDAQ:OCXOncocyte Corporation
2023/07/2206:16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:OCXOncocyte Corporation
2023/07/1419:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
2023/07/1100:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OCXOncocyte Corporation
2023/07/0407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
 검색 관련기사 보기:NASDAQ:OCX

최근 히스토리

NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
FX
USDGBP
US Dollar vs Sterling
PM
XAUUSD
Gold vs US Dollar
CCOM
SILVER
SILVER
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
FX
USDJPY
US Dollar vs Yen
CCOM
US500
US 500
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유